• About
  • Subscribe
  • Advertise
  • Contact
Wednesday, June 25, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home

Specsavers unveils new data as it completes OCT roll out

by Myles Hume
October 9, 2019
in Company updates & acquisitions, Equipment, Glaucoma, Local, Optometry
Reading Time: 3 mins read
A A
Share on FacebookShare on Twitter

Specsavers has completed its world-first initiative to incorporate optical coherence tomography (OCT) into the standard eye exam of every Australian patient, with the technology now installed in all of the company’s practices.

The announcement coincides with the release of new data showing Specsavers’ optometrists are detecting eye disease earlier than before.

For the past three years, the optical chain has been undertaking a $40 million program to install a Topcon Maestro Fully Automated OCT/Fundus Camera into each of its locations across Australia and New Zealand. The company’s Bacchus Marsh, Victoria, practice opened on 11 September, becoming the 334th and final Australian store to complete the fit out. Going forward, all new stores will be fitted with the technology as standard.

Specsavers is now the only national optometry provider to make OCT available to every one of its patients at no additional cost. During the next 12 months the company expects to conduct four million eye tests incorporating OCT, delivering the world’s largest every-patient eye disease detection program.

The roll out also means the company has access to an unrivalled dataset of more than 8.5 million patients. Specsavers optometrist Mr Michael Simpson said this was a “ground-breaking” development.

“When you compare the referral data before and after OCT was implemented, you can see the remarkable difference that using this technology on every patient is making,” he said.

“For example, from July to December 2017, when OCT was only used by 4% of Specsavers practices, 10,562 patients were referred to specialists for suspected glaucoma (0.68% of patients). In January to June 2018, when 83% of Specsavers practices used OCT, this number doubled to 20,516 (1.3% of patients).

“Similarly, diabetic retinopathy referrals have increased from 3,109 (of which 366 were identified with macular oedema) in that same 2017 date period, compared to 6,494 (of which 620 were identified with macular oedema) in 2019.”

The data also reveals 53% of Specsavers patients referred to ophthalmology for glaucoma are new suspects being referred for the first time, an indicator the technology is helping identify the suspected 50% of undiagnosed cases in Australia.

Additionally, first assessment glaucoma referrals are highest for those under the age of 49 (72.8% for people under the age of 40 and 68.7% for people 40-49), suggesting the use of OCT is helping to detect signs of glaucoma earlier.

“It’s exactly what we want to see because it validates the way we are using the technology,” Simpson added.

While the technology has helped glaucoma and diabetic retinopathy detection levels align closer with internationally published prevalence rates, the diagnostic sensitivity of OCT and the additional clinical information is also enabling optometrists to detect macular oedema at improved levels.

Glaucoma Australia (GA) CEO Ms Annie Gibbins said: “GA welcomes the widespread usage of OCT within the Specsavers network and believes it is having a tangible impact in the glaucoma arena.

“There are currently 300,000 Australians living with glaucoma but half of them don’t know they have it. The increasing use of OCT at the optometric level is helping contribute to a significant drop in the average age of diagnosis – in essence, we are picking up more patients and finding them sooner which is fantastic news.”

Diabetes Australia CEO Dr Greg Johnson said diabetes was a complex condition and early detection of problems and treatment is key to preventing vision loss.

“If optometrists can detect problems earlier utilising technology like OCT, then people can get earlier treatment, and damage is more likely to be prevented, meaning people can keep their sight.”

Topcon’s authorised Australian distributor Device Technologies has handled the installation, delivery and training for the Specsavers roll out. Specsavers expects to publish additional data with the release of the 2019 State of the Nation Eye Health Report next month.

Tags: diabetesglaucomaOCTSpecsavers

Related Posts

Cyber attackers are often driven by financial gain, with healthcare practices considered a lucrative target. Image: Lee Charlie/Shutterstock.com.

Don’t be blindsided by a cyber attack

by Staff Writer
June 24, 2025

Interruptions to service delivery and reputational damage are consequences of cyber attacks, which means cyber security should be a top...

Optometrist Michael Young’s daughter, a fourth-year optometry student at QUT, undergoing a visual field test on the VF2000 NEO. Image: Michael Young.

Perimetry remastered with VR device from BOC Instruments

by Staff Writer
June 24, 2025

A Californian-made virtual-reality visual field device has been on the wish list of many Australian optometry practice owners thanks to...

The 2025 meeting is taking place in Melbourne 14-17 November. Image: f11photo/stock.adobe.come & Prime Creative Media.

RANZCO has sights on biggest congress yet in 2025

by Staff Writer
June 24, 2025

RANZCO is anticipating its 2025 congress in Melbourne may be one of the largest yet. Since opening registration on 10...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited